Earnings calendar/BILI
Bilibili Inc. (BILI)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Aug 27, 2026
Consensus estimate row
EPS target
$0.23
Street estimate
Revenue target
$1.17B
Street estimate
Trailing EPS (avg 4Q)
$0.22
Beat rate last 4: 100%
Latest EPS YoY
+58.3%
vs 2025-05-20
Latest revenue YoY
+12.6%
How results look so far
Trailing revenue (avg 4Q)
$1.09B
Printed quarters
EPS beat rate (4Q)
100%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
May 19, 2026
EPS beat
EPS actual / est
$0.19 / $0.17
+11.8%
Revenue actual / est
$1.08B / $1.09B
-0.3%
Result
Target reached
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 8/27/2026upcoming | $0.23 | Pending | — | $1.17B | Pending | — |
| 5/19/2026 | $0.17 | $0.19 | +11.8% | $1.09B | $1.08B | -0.3% |
| 3/5/2026 | $0.27 | $0.28 | +3.7% | $1.16B | $1.19B | +2.3% |
| 2/19/2026upcoming | $0.27 | Pending | — | — | Pending | — |
| 11/13/2025 | $0.21 | $0.24 | +16.2% | $1.15B | $1.08B | -5.8% |
| 8/21/2025 | $0.17 | $0.18 | +5.9% | $1.02B | $1.02B | +0.3% |
| 5/20/2025 | $0.06 | $0.12 | +100.0% | $1.02B | $961.8M | -5.8% |
| 2/20/2025 | $0.14 | $0.15 | +7.1% | $953.0M | $1.06B | +11.2% |
| 11/14/2024 | $0.08 | $0.08 | +0.8% | $138.9M | $1.04B | +649.6% |
| 8/22/2024 | $-0.10 | $-0.09 | +11.9% | $140.5M | $843.2M | +500.0% |
| 5/23/2024 | $-0.17 | $-0.15 | +13.3% | $109.6M | $783.2M | +614.9% |
| 3/7/2024 | $-0.21 | $-0.19 | +9.3% | $122.1M | $896.4M | +634.1% |
| 11/29/2023 | $-0.26 | $-0.29 | -11.7% | $114.1M | $794.6M | +596.2% |
| 8/17/2023 | $-0.35 | $-0.33 | +5.0% | $111.3M | $732.1M | +557.9% |
| 6/1/2023 | $-0.41 | $-0.37 | +10.0% | $108.0M | $737.3M | +582.8% |
| 3/2/2023 | $-0.51 | $-0.48 | +6.5% | $893.2M | $897.2M | +0.4% |
| 11/29/2022 | $-0.65 | $-0.63 | +3.2% | $806.2M | $810.9M | +0.6% |
| 9/8/2022 | $-0.66 | $-0.75 | -13.8% | $730.7M | $732.4M | +0.2% |
| 6/9/2022 | $-0.64 | $-0.66 | -3.4% | $800.5M | $795.4M | -0.6% |
| 3/3/2022 | $-0.66 | $-0.66 | -0.2% | $905.4M | $907.7M | +0.3% |
| 11/17/2021 | $-0.66 | $-0.64 | +3.0% | $140.1M | $806.7M | +475.8% |
| 8/19/2021 | $-0.48 | $-0.35 | +27.1% | $123.2M | $695.1M | +464.0% |
| 5/13/2021 | $-0.36 | $-0.29 | +19.4% | $696.0M | $594.2M | -14.6% |
| 2/24/2021 | $-0.34 | $-0.29 | +14.7% | $656.5M | $588.3M | -10.4% |
| 11/18/2020 | $-0.37 | $-0.41 | -10.8% | $430.9M | $474.6M | +10.1% |
| 8/26/2020 | $-0.22 | $-0.19 | +13.6% | $430.9M | $370.7M | -14.0% |
| 5/18/2020 | $-0.13 | $-0.20 | -53.8% | $248.0M | $326.6M | +31.7% |
| 3/17/2020 | $-0.13 | $-0.15 | -15.4% | $314.2M | $291.3M | -7.3% |
| 11/18/2019 | $-0.13 | $-0.15 | -15.4% | $259.2M | $260.1M | +0.3% |
| 8/26/2019 | $-0.12 | $-0.11 | +8.3% | $230.1M | $223.8M | -2.8% |
| 5/13/2019 | $-0.13 | $-0.07 | +46.2% | $344.2M | $204.3M | -40.6% |
| 2/27/2019 | $-0.10 | $-0.07 | +30.0% | $247.6M | $176.5M | -28.7% |
| 11/20/2018 | $-0.09 | $-0.10 | -11.1% | $116.6M | $156.9M | +34.5% |
| 8/27/2018 | $-0.01 | $-0.01 | -61.3% | $218.0M | $155.0M | -28.9% |
| 5/23/2018 | $-0.09 | $-0.94 | -944.4% | $134.3M | $138.1M | +2.8% |
| 3/28/2018 | — | $-0.03 | — | — | $111.4M | — |
| 12/31/2017 | — | $-0.03 | — | — | $111.4M | — |
| 9/30/2017 | — | $-0.01 | — | — | $109.4M | — |
| 6/30/2017 | — | $-0.02 | — | — | $85.8M | — |
| 3/31/2017 | — | $-0.03 | — | — | $61.6M | — |
| 12/31/2016 | — | $-1.11 | — | — | $31.3M | — |
| 9/30/2016 | — | $-0.48 | — | — | $20.4M | — |
Need BILI data in your own agent or pipeline?
The earnings data on this page — report dates, consensus EPS/revenue estimates, actuals and surprise history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.